Khiron Life Sciences Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced total revenue was CAD 2.802 million compared to CAD 1.670 million a year ago. Net loss was CAD 4.796 million compared to CAD 5.712 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.05 a year ago. For the half year, total revenue was CAD 5.639 million compared to CAD 3.570 million a year ago. Net loss was CAD 10.290 million compared to CAD 14.949 million a year ago. Basic loss per share from continuing operations was CAD 0.07 compared to CAD 0.13 a year ago.